| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.55B | 51.91B | 55.32B | 43.07B | 28.55B | 17.05B |
| Gross Profit | 13.94B | 16.13B | 13.44B | 8.97B | 2.32B | 714.00M |
| EBITDA | 7.30B | 11.12B | 12.28B | 7.12B | 932.00M | -874.00M |
| Net Income | 4.72B | 7.09B | 9.69B | 4.39B | -3.11B | -5.08B |
Balance Sheet | ||||||
| Total Assets | 100.47B | 101.45B | 93.45B | 81.99B | 76.59B | 78.21B |
| Cash, Cash Equivalents and Short-Term Investments | 4.45B | 4.62B | 5.97B | 6.97B | 10.67B | 6.52B |
| Total Debt | 45.00B | 43.70B | 40.10B | 40.50B | 40.50B | 41.17B |
| Total Liabilities | 58.35B | 58.61B | 54.94B | 51.51B | 50.08B | 48.51B |
| Stockholders Equity | 42.11B | 42.84B | 38.51B | 30.47B | 26.51B | 29.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -57.00M | -619.00M | -1.62B | 5.31B | -9.53B |
| Operating Cash Flow | 0.00 | 2.86B | 2.10B | 741.00M | 6.30B | -6.73B |
| Investing Cash Flow | 0.00 | -3.48B | -3.02B | -2.69B | -1.45B | -2.88B |
| Financing Cash Flow | 0.00 | -694.00M | -524.00M | -369.00M | -559.00M | 10.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥182.56B | 17.88 | 5.78% | 1.49% | 0.82% | -1.72% | |
72 Outperform | ¥129.00B | 6.59 | 11.58% | 1.62% | 9.81% | 30.20% | |
71 Outperform | ¥101.56B | 19.55 | ― | 1.38% | -3.56% | -30.17% | |
68 Neutral | ¥2.60T | 7.93 | 5.18% | 1.98% | 3.15% | -63.65% | |
66 Neutral | ¥670.21B | 3.88 | 3.12% | 2.83% | -0.64% | -65.65% | |
66 Neutral | ¥558.73B | 22.37 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |